Nov 11, 2021 / 02:40PM GMT
Matthew Stephan Miksic - Crédit Suisse AG - Research Division - Senior Research Analyst
Right. Well, listen, I apologize for the late start. So we're 5 minutes in, but hopefully we'll be able to get through some of the things we'd like to talk about. Gary and Dave, thanks so much for joining us. My name is Matt Miksic. I cover Medical Devices at Crédit Suisse. We're very pleased to have the team from Organogenesis with us today, Gary Gillheeney and Dave Francisco, thanks again.
Gary S. Gillheeney - Organogenesis Holdings Inc. - President, CEO & Director
Thank you, Matt. We're happy to be here.
Questions and Answers:
Matthew Stephan Miksic - Crédit Suisse AG - Research Division - Senior Research AnalystSo we've been starting many of the sessions this week with questions around the environment and staffing and COVID surge and so on. But I thought given that the amount of attention that has been given to Affinity over the past 4 to 6 weeks and some of the
Trustpilot
